Committees

The PCC will be responsible for the implementation of LEAD, with a special focus on the scientific and training content. In regards of the selection process, the PCC will have a coordination role putting together the Scientific Review Panel (SRP) and ranking the candidates based on the SRP’s and Selection Committees scores. The PCC will consist of:

• Katrine Sanne-Hansen, Program coordinator
• Séverine Le Bras, Program manager
• Assoc. professor, Luis Arnes, head of BRIC's postdoc program
• Professor Janine Erler
• Professor Anders Lund, director of BRIC

Scientific review panels consisting of international independent scientific reviewers covering the scientific scope within LEAD will be assembled for each call. Each BRIC PI will suggest up to four experts in their field to the LEAD Programme Coordination Committee, excluding close collaborators with shared publications. The PCC will from the suggestions put together a review panel with three independent experts, who will review applicants within a given area. Each evaluator will maximum evaluate 6 applicants.
The evaluators in a panel will individually score the applicants using the predefined criteria and scoring system and assess their main strength and weaknesses. Their evaluations are submitted to the programme manager.

The Selection Committee (SC) will perform on-site oral interviews of the shortlisted candidates and will evaluate the applicants using predefined evaluation criteria and scoring system. The SC consists of:

• Professor Martin Jechlinger, EMBL, Heidelberg
• Professor and Director Anne Grapin-Botton, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden
• Daniel Timmermann, Head of global drug discovery innovation, Novo Nordisk A/S
• Nordic Bioscience
• Four appointed non-recruiting BRIC group leaders

 The Advisory Board will advise LEAD’s coordinator and PCC on selection processes, training portfolio and career development activities to ensure excellence in all project phases. The AB consists of four international, intersectoral experts:

• Professor and postdoc dean at Netherlands Cancer Institute Fred van Leeuwen
• Daniel Timmermann, Head of global drug discovery innovation, Novo Nordisk A/S
• Sarah Blackford, career consultant, Bioscience Careers
• Marina Cacace, social scientist, Knowledge and Innovation institute

The AB will meet with PCC at kick-off and as a minimum twice during the programme (physical and Skype). Also, they will together with the coordinator and PCC evaluate LEAD at the end of the programme, giving recommendations on long-term sustainability and future adaptations.

Prof. Nils Billestrup, former head of the Graduate School at the Faculty of Health and Medical Sciences and current acting ‘named person’, will support the fellows  during implementation of the program. 

The Faculty of Health and Medical Sciences and the Faculty of Science, UCPH has an ethical committee (Research Ethics Committee of Science and Health), with strong ethical expertise with specific knowledge of ethics in EU projects. Prof. Lisbeth E. Knudsen chairs the committee and has in that role acted as ethical advisor for UCPH’s DP COFUND projects and will do so also for LEAD.